Life Sciences Market Research Report
Report Filter Reset All
Sort By Price
Published Date
Category
Publishers
Report Type
Continents
Regions
Global Soliris Drug Market Research Report 2019
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome...
$2,900.00 28 February, 2019 | QYResearch
Global Soliris Drug Market Research Report 2019
$2,900.00 | 28 February, 2019 | QYResearch
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremi...
Global Lenalidomide Drug Market Research Report 2019
It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic treatment. Lenalidomide has also shown effica...
$2,900.00 28 February, 2019 | QYResearch
Global Lenalidomide Drug Market Research Report 2019
$2,900.00 | 28 February, 2019 | QYResearch
It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic treatment. Lenalidomide has also sh...
Global Rituximab Drug Market Research Report 2019
Rituximab, sold under the brand name Rituxan among others, is a medication used to treat certain autoimmune diseases and types of cancer. The global Rituxim...
$2,900.00 28 February, 2019 | QYResearch
Global Rituximab Drug Market Research Report 2019
$2,900.00 | 28 February, 2019 | QYResearch
Rituximab, sold under the brand name Rituxan among others, is a medication used to treat certain autoimmune diseases and types of cancer. The glob...
Global Afinitor Drug Market Research Report 2019
Everolimus is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an inhibitor of mammalian target of rapamycin (mTOR). Th...
$2,900.00 28 February, 2019 | QYResearch
Global Afinitor Drug Market Research Report 2019
$2,900.00 | 28 February, 2019 | QYResearch
Everolimus is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an inhibitor of mammalian target of rapamycin (...
Global Xeljanz (tofacitnib) Drug Market Research Report 2019
Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis The ...
$2,900.00 28 February, 2019 | QYResearch
Global Xeljanz (tofacitnib) Drug Market Research Report 2019
$2,900.00 | 28 February, 2019 | QYResearch
Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative col...
Global Women's Health Market Research Report 2019
In this report, we study the drugs for women's health The global Women's Health market is valued at xx million US$ in 2018 is expected to reach xx million U...
$2,900.00 28 February, 2019 | QYResearch
Global Women's Health Market Research Report 2019
$2,900.00 | 28 February, 2019 | QYResearch
In this report, we study the drugs for women's health The global Women's Health market is valued at xx million US$ in 2018 is expected to reach xx...
Global Intracranial Shunt Device Market Research Report 2019
Cerebral shunts are commonly used to treat hydrocephalus, the swelling of the brain due to excess buildup of cerebrospinal fluid (CSF). If left unchecked, th...
$2,900.00 28 February, 2019 | QYResearch
Global Intracranial Shunt Device Market Research Report 2019
$2,900.00 | 28 February, 2019 | QYResearch
Cerebral shunts are commonly used to treat hydrocephalus, the swelling of the brain due to excess buildup of cerebrospinal fluid (CSF). If left unc...
Global Ulcerative Colitis Drugs Market Research Report 2019
Anti-inflammatory drugs are often the first step in the treatment of ulcerative colitis. They include: 5-aminosalicylates. Examples of this type of medicatio...
$2,900.00 28 February, 2019 | QYResearch
Global Ulcerative Colitis Drugs Market Research Report 2019
$2,900.00 | 28 February, 2019 | QYResearch
Anti-inflammatory drugs are often the first step in the treatment of ulcerative colitis. They include: 5-aminosalicylates. Examples of this type of...
Global Ulcerative Colitis Treatment Market Research Report 2019
Anti-inflammatory drugs are often the first step in the treatment of ulcerative colitis. They include: 5-aminosalicylates. Examples of this type of medicatio...
$2,900.00 28 February, 2019 | QYResearch
Global Ulcerative Colitis Treatment Market Research Report 2019
$2,900.00 | 28 February, 2019 | QYResearch
Anti-inflammatory drugs are often the first step in the treatment of ulcerative colitis. They include: 5-aminosalicylates. Examples of this type of...
Global Drug for Ulcerative Colitis Market Research Report 2019
Anti-inflammatory drugs are often the first step in the treatment of ulcerative colitis. They include: 5-aminosalicylates. Examples of this type of medicatio...
$2,900.00 28 February, 2019 | QYResearch
Global Drug for Ulcerative Colitis Market Research Report 2019
$2,900.00 | 28 February, 2019 | QYResearch
Anti-inflammatory drugs are often the first step in the treatment of ulcerative colitis. They include: 5-aminosalicylates. Examples of this type of...
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
